Barinthus Biotherapeutics (BRNS) Capital Expenditures (2020 - 2025)
Barinthus Biotherapeutics (BRNS) reported Capital Expenditures of $32000.0 for Q2 2025, down 83.33% on a YoY basis from $192000.0 in Q2 2024, and up 540.0% quarter-over-quarter from $5000.0 in Q1 2025.
Barinthus Biotherapeutics (BRNS) Capital Expenditures (2020 - 2025) Analysis & Trends
Barinthus Biotherapeutics has reported Capital Expenditures for 6 years, with the latest figure at $32000.0 in Q2 2025.
- For the quarter ending Q2 2025, Capital Expenditures fell 83.33% year-over-year to $32000.0; the trailing twelve-month figure through Mar 2026 stood at $32000.0 (down 94.57% YoY), and the FY2025 full-year result was $37000.0, down 95.85% from the prior year.
- Capital Expenditures for Q2 2025 stood at $32000.0, up from $5000.0 in the prior quarter.
- The five-year high for Capital Expenditures was $5.1 million in Q3 2023, with the low at -$5.5 million in Q4 2023.
- Historically, Capital Expenditures has averaged $461111.1 across 5 years, with a median of $350000.0 in 2021.
- Annual changes were most pronounced in 2021 — Capital Expenditures soared 1681.82% — and 2023, when it slumped 1034.98%.
- Barinthus Biotherapeutics' Capital Expenditures stood at $424000.0 in 2021, then jumped by 38.21% to $586000.0 in 2022, then tumbled by 1034.98% to -$5.5 million in 2023, then soared by 105.07% to $278000.0 in 2024, then plunged by 88.49% to $32000.0 in 2025.
- The last three Capital Expenditures figures came in at $32000.0 (Q2 2025), $5000.0 (Q1 2025), and $278000.0 (Q4 2024), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | - |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | - |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | - |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | - |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | - |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 133.40 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -63,220.27 |
| 10 | Barinthus Biotherapeutics | 27.08 Mn | -40.03 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 32,000.00 |
| Jun 30, 2025 | 32,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Mar 31, 2025 | 5,000.00 |
| Dec 31, 2024 | 278,000.00 |
| Dec 31, 2024 | 278,000.00 |
| Sep 30, 2024 | 114,000.00 |
| Sep 30, 2024 | 114,000.00 |
| Jun 30, 2024 | 192,000.00 |
| Jun 30, 2024 | 192,000.00 |
| Mar 31, 2024 | 308,000.00 |
| Mar 31, 2024 | 308,000.00 |
| Dec 31, 2023 | -5.48 Mn |
| Dec 31, 2023 | -5.48 Mn |
| Sep 30, 2023 | 5.06 Mn |
| Sep 30, 2023 | 5.06 Mn |
| Jun 30, 2023 | -1.74 Mn |
| Jun 30, 2023 | -1.74 Mn |
| Mar 31, 2023 | 2.25 Mn |
| Mar 31, 2023 | 2.25 Mn |